constipation due to glp 1 Why Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of GLP-1 and GIP-1 agonists like semaglutide (Wegovy®) or tirzepatide (Zepbound®). Left untreated, it can lead constipation due to glp 1

These medications have changed the conversation around weight loss and type 2 diabetes, but if you live with thyroid disease, the questions are more complicated: Are they safe

To understand why Retatrutide is generating such intense excitement, we have to look at the biology of how your body regulates weight

Furthermore, there is an increased risk of gallbladder-related disorders, which is consistent with the known association between rapid weight loss and gallbladder-related disorders [41, 42]

Considering the large variety of therapies available, each with different attributes and mechanisms of action, along with the heterogenous nature of T2DM, the treatment landscape is understandably complicated

Tirzepatide is a dual GIP/GLP-1 receptor agonist administered as a weekly subcutaneous injection, producing up to 20.9% weight loss at 72 weeks in Phase 3 trials